2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | 98.298 | 416.355 | 479.830 | 969.598 | 991.343 | 990.516 | 987.716 | 1.164.205 | 2.549.954 |
Total Income - EUR | - | 98.678 | 416.826 | 480.026 | 969.962 | 994.268 | 996.555 | 992.027 | 1.171.666 | 2.559.001 |
Total Expenses - EUR | - | 74.892 | 247.415 | 346.616 | 670.497 | 570.695 | 569.664 | 543.449 | 861.011 | 2.152.408 |
Gross Profit/Loss - EUR | - | 23.786 | 169.411 | 133.410 | 299.465 | 423.573 | 426.890 | 448.577 | 310.655 | 406.593 |
Net Profit/Loss - EUR | - | 22.803 | 165.246 | 128.611 | 289.823 | 416.157 | 418.684 | 440.987 | 298.911 | 344.280 |
Employees | - | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
Check the financial reports for the company - Biolife Caviar Srl
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | 0 | 0 | 7.859 | 10.895 | 9.710 | 115.212 | 99.976 | 94.973 | 349.189 |
Current Assets | - | 70.420 | 194.851 | 273.333 | 564.004 | 593.901 | 556.007 | 903.184 | 543.896 | 1.800.132 |
Inventories | - | 26.641 | 4.366 | 19.721 | 171.553 | 211.414 | 259.711 | 235.052 | 72.075 | 238.408 |
Receivables | - | 26.799 | 89.606 | 78.635 | 430.058 | 358.616 | 192.028 | 633.078 | 464.201 | 1.454.983 |
Cash | - | 16.979 | 100.878 | 174.976 | -37.606 | 23.872 | 104.268 | 35.054 | 7.620 | 106.741 |
Shareholders Funds | - | 22.847 | 165.299 | 226.452 | 427.597 | 556.555 | 558.594 | 595.758 | 488.537 | 1.360.826 |
Social Capital | - | 45 | 44 | 86 | 84 | 83 | 81 | 81 | 81 | 400 |
Debts | - | 47.572 | 29.552 | 54.741 | 147.302 | 47.056 | 112.624 | 407.402 | 150.333 | 788.495 |
Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 1 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
Main CAEN | "4638 - 4638" | |||||||||
CAEN Financial Year |
4638
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Biolife Caviar Srl